• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

约氏疟原虫尼日尔株氯喹抗性的诱导

Induction of chloroquine resistance in Plasmodium yoelii nigeriensis.

作者信息

Kimbi H K, Fagbenro-Beyioku A F

机构信息

Department of Medical Microbiology and Parasitology, College of Medicine, University of Lagos, Nigeria.

出版信息

East Afr Med J. 1996 Oct;73(10):634-5.

PMID:8997840
Abstract

Chloroquine resistance was induced in Plasmodium yoelii nigeriensis by the method of drug pressure. Twenty five albino mice were used at each passage and each of them was inoculated intra-peritoneally with approximately 10(5) erythrocytes infected with the parasite. The first fifteen mice divided into three groups of five mice each were treated with different sub-curative doses of chloroquine which usually cleared the infection for a few days before recrudescence. Inocula for passages to the next set of mice was made from the recrudesced infection. The sub-curative dose was progressively increased as rapidly as the build-up of parasitaemia permitted. The last ten mice divided into two groups of five mice each were used in the 'two percent test' to assess the level of resistance in the parasite. Full resistance to the maximum tolerated dose of chloroquine to the host mouse (80 mg/kg body weight) was reached at passage 20.

摘要

通过药物压力法在约氏疟原虫尼氏亚种中诱导氯喹抗性。每次传代使用25只白化小鼠,每只小鼠经腹腔接种约10(5)个感染该寄生虫的红细胞。将最初的15只小鼠分成三组,每组5只,用不同的亚治疗剂量氯喹进行治疗,这些剂量通常能在感染复发前清除感染数天。用于传代至下一组小鼠的接种物取自复发的感染。随着寄生虫血症的积累允许,亚治疗剂量逐渐快速增加。最后10只小鼠分成两组,每组5只,用于“2%试验”以评估寄生虫的抗性水平。在第20代时达到了对宿主小鼠最大耐受剂量氯喹(80毫克/千克体重)的完全抗性。

相似文献

1
Induction of chloroquine resistance in Plasmodium yoelii nigeriensis.约氏疟原虫尼日尔株氯喹抗性的诱导
East Afr Med J. 1996 Oct;73(10):634-5.
2
Efficacy of Cymbopogon giganteus and Enantia chrantha against chloroquine resistant Plasmodium yoelii nigeriensis.巨桉叶香茅和恩氏非洲楝对氯喹抗性约氏疟原虫尼日尔株的疗效。
East Afr Med J. 1996 Oct;73(10):636-7.
3
Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice.氯喹与肿瘤坏死因子对正常及约氏疟原虫尼氏亚种感染小鼠肝脏氧化应激和抗氧化防御的拮抗作用。
In Vivo. 2002 Jan-Feb;16(1):67-70.
4
Status of hepatic oxidative stress and antioxidant defense systems during chloroquine treatment of Plasmodium yoelii nigeriensis infected mice.约氏疟原虫尼氏亚种感染小鼠氯喹治疗期间肝脏氧化应激和抗氧化防御系统的状态
In Vivo. 1999 Nov-Dec;13(6):547-50.
5
Immunization of albino mice using chloroquine attenuated Plasmodium yoelli nigeriensis.使用氯喹对白化小鼠进行免疫接种,可使约氏疟原虫尼日尔亚种减毒。
East Afr Med J. 1995 Nov;72(11):742-3.
6
Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice.克拉霉素是一种细胞色素 P450 抑制剂,能逆转感染伯氏疟原虫尼日利亚株的瑞士小鼠中的氯喹耐药性。
Parasitology. 2011 Aug;138(9):1069-76. doi: 10.1017/S0031182011000850. Epub 2011 Jul 15.
7
Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis.酮康唑对约氏疟原虫尼日利亚株甲氟喹耐药性的逆转作用
Exp Parasitol. 2004 Jul-Aug;107(3-4):115-9. doi: 10.1016/j.exppara.2004.06.001.
8
Adoptive transfer of immunity induced with chloroquine attenuated Plasmodium yoelii nigeriensis from immune to immunologically naive mice.用氯喹诱导产生的免疫的过继转移,可将约氏疟原虫尼氏株从免疫小鼠转移至未免疫的小鼠,从而使后者病情减轻。
West Afr J Med. 1997 Jan-Mar;16(1):44-7.
9
Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.角鲨胺与氯喹联合对约氏疟原虫和伯氏疟原虫在小鼠体内生长的抗疟特性
Trop Biomed. 2006 Dec;23(2):140-6.
10
Plasmodium yoelii: activity of azithromycin in combination with pyrimethamine or sulfadoxine against blood and sporozoite induced infections in Swiss mice.约氏疟原虫:阿奇霉素与乙胺嘧啶或磺胺多辛联合用药对瑞士小鼠血液感染及子孢子诱导感染的活性
Exp Parasitol. 2004 Jul-Aug;107(3-4):120-4. doi: 10.1016/j.exppara.2004.05.005.